NO176839C - Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser - Google Patents

Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser

Info

Publication number
NO176839C
NO176839C NO881567A NO881567A NO176839C NO 176839 C NO176839 C NO 176839C NO 881567 A NO881567 A NO 881567A NO 881567 A NO881567 A NO 881567A NO 176839 C NO176839 C NO 176839C
Authority
NO
Norway
Prior art keywords
ligands
metal complexes
preparation
methods
well
Prior art date
Application number
NO881567A
Other languages
English (en)
Norwegian (no)
Other versions
NO176839B (no
NO881567L (no
NO881567D0 (no
Inventor
Michel Schaefer
Didier Doucet
Bruno Bonnemain
Dominique Meyer
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of NO881567D0 publication Critical patent/NO881567D0/no
Publication of NO881567L publication Critical patent/NO881567L/no
Publication of NO176839B publication Critical patent/NO176839B/no
Publication of NO176839C publication Critical patent/NO176839C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Paints Or Removers (AREA)
NO881567A 1987-04-14 1988-04-12 Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser NO176839C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705288A FR2614020B1 (fr) 1987-04-14 1987-04-14 Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.

Publications (4)

Publication Number Publication Date
NO881567D0 NO881567D0 (no) 1988-04-12
NO881567L NO881567L (no) 1988-10-17
NO176839B NO176839B (no) 1995-02-27
NO176839C true NO176839C (no) 1995-06-14

Family

ID=9350106

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881567A NO176839C (no) 1987-04-14 1988-04-12 Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser

Country Status (22)

Country Link
EP (1) EP0287465B1 (da)
JP (1) JP2675058B2 (da)
KR (1) KR880012572A (da)
CN (1) CN1022411C (da)
AT (1) ATE85052T1 (da)
AU (1) AU606146B2 (da)
DD (1) DD293113A5 (da)
DE (1) DE3877799T2 (da)
DK (1) DK170946B1 (da)
ES (1) ES2053779T3 (da)
FI (1) FI93830C (da)
FR (1) FR2614020B1 (da)
GR (1) GR3007495T3 (da)
HR (1) HRP920514A2 (da)
HU (1) HU198501B (da)
IE (1) IE62582B1 (da)
IL (1) IL86059A (da)
NO (1) NO176839C (da)
PT (1) PT87216B (da)
SI (1) SI8810742A (da)
YU (1) YU46691B (da)
ZA (1) ZA882552B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US5362476A (en) * 1984-10-18 1994-11-08 Board Of Regents, The University Of Texas System Alkyl phosphonate polyazamacrocyclic cheates for MRI
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
FR2637895B1 (fr) * 1988-10-14 1992-11-06 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands
AU617338B2 (en) * 1987-07-16 1991-11-28 Nycomed As Aminopolycarboxylic acids and derivatives thereof
JP2833766B2 (ja) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト アミノポリカルボン酸およびその誘導体
US5531978A (en) * 1987-07-16 1996-07-02 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
RU2059642C1 (ru) * 1987-12-24 1996-05-10 Бракко Индустрия Кимика С.п.А Хелаты гадолиния и способ их получения
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
US5446145A (en) * 1990-01-19 1995-08-29 Nycomed Salutar, Inc. Polychelant compounds
CA2069886A1 (en) * 1989-10-23 1991-04-24 David Love Multi-site metal chelating agents
US5021409A (en) * 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU6709390A (en) * 1989-12-22 1991-06-27 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane
US5679810A (en) * 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
EP0598753B1 (en) * 1991-07-19 1998-03-18 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU5019193A (en) * 1992-08-19 1994-03-15 Mallinckrodt Medical, Inc. Ligands for ga-68 pet heart applications
US6204259B1 (en) 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
HUT72671A (en) * 1993-11-26 1996-05-28 Dow Chemical Co Process for preparing polyazamacrocycles
AU706642B2 (en) * 1994-04-22 1999-06-17 G.D. Searle & Co. Diagnostic image analysis with metal complexes
EP0846003A1 (en) 1995-08-17 1998-06-10 Monsanto Company Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
EP0844889A1 (en) * 1995-08-17 1998-06-03 Monsanto Company Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
JP2003501488A (ja) 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
EP1390081A2 (en) 2001-01-08 2004-02-25 Neorx Corporation Therapeutic and diagnostic compounds, compositions, and methods
FR2830253B1 (fr) * 2001-09-28 2005-02-04 Air Liquide Nouveau procede de preparation de macrocycles azotes c-fonctionnalises et nouveaux intermediaires obtenus
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
WO2016145156A1 (en) * 2015-03-10 2016-09-15 Emory University Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
US10709697B2 (en) 2015-07-16 2020-07-14 Emory University Bis-amines, compositions, and uses related to CXCR4 inhibition
CN106588925B (zh) * 2016-12-05 2018-03-30 天津羲泽润科技有限公司 一种制备1,4,7,10‑四氮杂‑2,6‑吡啶环蕃的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO149961C (no) * 1981-06-01 1984-07-25 Borregaard Ind Fremgangsmaate for fremstilling av n-(2-hydroksyetyl)-derivater av makrocykliske polyaminer, inneholdende flere nitrogenatomer i 1,4-forhold i ringen
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
JPS60202869A (ja) * 1984-03-26 1985-10-14 Ajinomoto Co Inc 大環状ポリアミン誘導体及びその用途
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
EP0232751B1 (en) * 1986-01-23 1991-09-11 E.R. Squibb & Sons, Inc. 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8719041D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds

Also Published As

Publication number Publication date
DE3877799D1 (de) 1993-03-11
DK202788A (da) 1988-10-15
FI881708A0 (fi) 1988-04-13
JP2675058B2 (ja) 1997-11-12
HRP920514A2 (hr) 1994-04-30
AU606146B2 (en) 1991-01-31
HUT47075A (en) 1989-01-30
NO176839B (no) 1995-02-27
FI93830B (fi) 1995-02-28
SI8810742A (en) 1996-08-31
EP0287465A1 (fr) 1988-10-19
DD293113A5 (de) 1991-08-22
ZA882552B (en) 1988-09-27
IE62582B1 (en) 1995-02-08
DE3877799T2 (de) 1993-07-22
PT87216A (pt) 1988-05-01
FR2614020B1 (fr) 1989-07-28
CN1022411C (zh) 1993-10-13
FR2614020A1 (fr) 1988-10-21
IL86059A0 (en) 1988-09-30
EP0287465B1 (fr) 1993-01-27
HU198501B (en) 1989-10-30
DK170946B1 (da) 1996-03-25
IL86059A (en) 1993-01-14
CN88102139A (zh) 1988-10-26
NO881567L (no) 1988-10-17
YU74288A (en) 1990-04-30
IE881114L (en) 1988-10-14
PT87216B (pt) 1992-07-31
ES2053779T3 (es) 1994-08-01
GR3007495T3 (da) 1993-07-30
ATE85052T1 (de) 1993-02-15
FI93830C (fi) 1995-06-12
DK202788D0 (da) 1988-04-13
YU46691B (sh) 1994-04-05
KR880012572A (ko) 1988-11-28
FI881708L (fi) 1988-10-15
JPH01211573A (ja) 1989-08-24
NO881567D0 (no) 1988-04-12
AU1461188A (en) 1988-10-20

Similar Documents

Publication Publication Date Title
NO176839C (no) Ligander og fremgangsmåte for deres fremstilling, metallkomplekser dannet med disse ligander samt diagnostisk preparat og röntgenkontrastmiddel omfattende ovennevnte metallkomplekser
IS2127B (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
NO173767C (no) Magnetisk resonansbildeforsterkende blanding
NO301829B1 (no) 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse
NO923739D0 (no) Kontrastmidler
DE3766157D1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
EP0727224A3 (en) Diagnostic agents
IL109115A0 (en) Methods for measurement of nmr-detectable xenobiotic compounds
DK0470188T3 (da) Hidtil ukendte magnetiske resonans-imaging-midler
ATE131072T1 (de) Kerne für technetium-radioarzneimittel.
DK0570575T3 (da) Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf
FI885295L (fi) Substituoituja dikarboksyylihappo-bis(3,5-dikarbamoyyli-2,4,6-trijodianilideja) menetelmä niiden valmistamiseksi sekä niiden käyttö röntgenvarjoaineiden valmistamiseksi
DE68922686D1 (de) Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
ATE134988T1 (de) Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen
IT1265100B1 (it) Complessi di ferro ad elevata nuclearita' e loro utilizzo come mezzi di contrasto in magnetic resonance imaging